AR230007A1 - Un metodo para proteger una preparacion liofilizada que contiene beta-lactama antibacteriana - Google Patents

Un metodo para proteger una preparacion liofilizada que contiene beta-lactama antibacteriana

Info

Publication number
AR230007A1
AR230007A1 AR285821A AR28582181A AR230007A1 AR 230007 A1 AR230007 A1 AR 230007A1 AR 285821 A AR285821 A AR 285821A AR 28582181 A AR28582181 A AR 28582181A AR 230007 A1 AR230007 A1 AR 230007A1
Authority
AR
Argentina
Prior art keywords
lactam
protect
preparation containing
lyophilized preparation
containing antibacterial
Prior art date
Application number
AR285821A
Other languages
English (en)
Original Assignee
Shionogi Y Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi Y Co Ltd filed Critical Shionogi Y Co Ltd
Application granted granted Critical
Publication of AR230007A1 publication Critical patent/AR230007A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AR285821A 1980-06-23 1981-06-23 Un metodo para proteger una preparacion liofilizada que contiene beta-lactama antibacteriana AR230007A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (1)

Publication Number Publication Date
AR230007A1 true AR230007A1 (es) 1984-02-29

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
AR285821A AR230007A1 (es) 1980-06-23 1981-06-23 Un metodo para proteger una preparacion liofilizada que contiene beta-lactama antibacteriana

Country Status (31)

Country Link
US (1) US4418058A (es)
JP (1) JPS5711909A (es)
KR (1) KR840000693B1 (es)
AR (1) AR230007A1 (es)
AT (1) AT380790B (es)
AU (1) AU541627B2 (es)
BE (1) BE889351A (es)
BG (1) BG37991A3 (es)
CA (1) CA1164801A (es)
CH (1) CH648210A5 (es)
CS (1) CS221835B2 (es)
DD (1) DD159879A5 (es)
DE (1) DE3124592A1 (es)
DK (1) DK158443C (es)
ES (1) ES8203887A1 (es)
FI (1) FI75490C (es)
FR (1) FR2484835A1 (es)
GB (1) GB2078737B (es)
GR (1) GR75646B (es)
HU (1) HU183494B (es)
IE (1) IE51331B1 (es)
IL (1) IL63136A (es)
IT (1) IT1144812B (es)
NL (1) NL191777C (es)
NO (1) NO156036C (es)
NZ (1) NZ197414A (es)
PT (1) PT73239B (es)
RO (1) RO82720B (es)
SE (1) SE460702B (es)
YU (1) YU44416B (es)
ZA (1) ZA814203B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
AU2001271037A1 (en) * 2000-07-13 2002-01-30 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical compositions containing dds compounds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (es) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
NO774315L (no) * 1976-12-17 1978-06-20 Scherico Ltd Fremgangsmaate ved fremstilling av antibiotiske formuleringer
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
DD159879A5 (de) 1983-04-13
IL63136A0 (en) 1981-09-13
JPS6364405B2 (es) 1988-12-12
FI811948L (fi) 1981-12-24
NO156036B (no) 1987-04-06
ES503283A0 (es) 1982-04-01
BE889351A (fr) 1981-10-16
ATA278881A (de) 1985-12-15
YU44416B (en) 1990-08-31
GB2078737A (en) 1982-01-13
PT73239B (en) 1982-07-22
ZA814203B (en) 1982-09-29
RO82720A (ro) 1984-05-23
NL8102943A (nl) 1982-01-18
IE811347L (en) 1981-12-23
AU7209781A (en) 1983-01-06
FR2484835B1 (es) 1983-07-01
FI75490B (fi) 1988-03-31
AT380790B (de) 1986-07-10
HU183494B (en) 1984-05-28
ES8203887A1 (es) 1982-04-01
NL191777C (nl) 1996-08-02
KR840000693B1 (ko) 1984-05-21
IL63136A (en) 1984-07-31
CS221835B2 (en) 1983-04-29
FR2484835A1 (fr) 1981-12-24
YU157381A (en) 1984-10-31
DK158443C (da) 1990-10-08
NZ197414A (en) 1984-10-19
SE460702B (sv) 1989-11-13
AU541627B2 (en) 1985-01-17
DE3124592A1 (de) 1982-02-11
NO812090L (no) 1981-12-28
KR830005848A (ko) 1983-09-14
GR75646B (es) 1984-08-02
SE8103904L (sv) 1981-12-24
CA1164801A (en) 1984-04-03
RO82720B (ro) 1984-07-30
JPS5711909A (en) 1982-01-21
CH648210A5 (de) 1985-03-15
FI75490C (fi) 1988-07-11
IT8167863A0 (it) 1981-06-22
DE3124592C2 (es) 1990-12-20
NO156036C (no) 1987-07-15
DK274981A (da) 1981-12-24
NL191777B (nl) 1996-04-01
IE51331B1 (en) 1986-12-10
PT73239A (en) 1981-07-01
IT1144812B (it) 1986-10-29
GB2078737B (en) 1984-03-14
DK158443B (da) 1990-05-21
US4418058A (en) 1983-11-29
BG37991A3 (en) 1985-09-16

Similar Documents

Publication Publication Date Title
DK474881A (da) Chlorsubstituerede disaccharider
BE889498A (fr) Etui d'emballage
ES554507A0 (es) Un metodo para preparar una composicion de resina acrilica no gelificada
AR230007A1 (es) Un metodo para proteger una preparacion liofilizada que contiene beta-lactama antibacteriana
DK60581A (da) Panserbrydende masseprojektil med stabelformet forpenetrator
FI832004L (fi) Foerfarande foer framstaellning av 1-sulfo-2-oxoazetidinderivat
ES502676A0 (es) Un procedimiento para la preparacion de una composicion ter-moplastica transparente
ATA117281A (de) Verpackungsmaschine
FI833371A (fi) Emballage
ES499218A0 (es) Un metodo para fabricar una fibra
ES278359Y (es) Dispositivo para mantener unidos una pluralidad de recipientes
ES505393A0 (es) Un metodo para formar una composicion explosiva permisible.
BR8101304A (pt) Processo para impedir a aglutinacao de poliois
ES496885A0 (es) Metodo para controlar una locomotora
AR229686A1 (es) Metodo para proteger una composicion filmogena que comprende algodon o polivinil cloruro y la composicion resultante
AR226448A1 (es) Maquina envasadora
JPS55143238A (en) Cotton packing method
FI813451L (fi) Skaolformad foerpackning
AT364314B (de) Verpackungskarton
KR860004793U (ko) 포장용 상자
BR6400241U (pt) Embalagem
BR6000721U (pt) Embalagem
BR6000898U (pt) Embalagem
PT7064U (pt) Embalagem
SE8005325L (sv) Forpackning